The study titled “A Review of Ivermectin Use in Cancer Patients: Is it Time to Repurpose the Ivermectin in Cancer Treatment?” was just published in the journal Acta Poloniae Pharmaceutica – Drug Research:
We now know that ivermectin exerts over 12 distinct anti-cancer mechanisms across 12 cancer types — while COMPLETE REMISSION of Stage IV cancers using fenbendazole has been documented. This vital line of cancer research was set back more than HALF A CENTURY — and millions of cancer victims have paid the price.
Declassified CIA Cancer Document: https://t.co/WUBUa45V2m
Fenbendazole Linked to Remission or Near-Remission in Three Stage IV Cancer Patients: https://t.co/o6LqxGrYy9
Ivermectin Shows Striking Anticancer Potential and Remarkable Safety: https://t.co/6xicZPMqBQ pic.twitter.com/53qFRZHdng
— Nicolas Hulscher, MPH (@NicHulscher) March 14, 2026
